FY23 task order e - 126330 B320 trailer
Ended Awarded Last action
- Contract number
- 75N91023F00012
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,266,630
Award facts
- Contract value 100% obligated
- $2,266,630.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,266,630 |
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 27, 2023, with a ceiling value of $2.27 million and an ultimate completion date of August 31, 2026, under a cost-plus-fixed-fee pricing structure for FY23 Task Order E – 126330 B320 Trailer and its period of performance extension.
Place of performance is Frederick, MD 21702. Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc. and operates as an FFRDC contractor for NCI and NIH, providing biomedical research and facilities support services.
In FY2024, the order invoiced $343 thousand across 0.5 FTEs and 1,092 contractor hours at a derived government-paid rate of $314.53 per hour. The prime self-performed all reported work with no subcontractors.
Quick answers
Who was awarded contract 75N91023F00012?
75N91023F00012 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 27, 2023.
How much is contract 75N91023F00012 worth?
The government has obligated $2,266,630 on 75N91023F00012.
Is contract 75N91023F00012 an order under another contract?
Yes. 75N91023F00012 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91023F00012 competed?
The extent of competition for 75N91023F00012 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award